ストックスクリーナーアプリを入手
23.00
1.91%
0.43
アフターアワーズ：
22.98
-0.02
-0.09%
前日終値:
$22.57
開ける：
$22.79
24時間の取引高:
10,350
Relative Volume:
0.41
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.80%
1か月 パフォーマンス:
+6.58%
6か月 パフォーマンス:
+2.00%
1年 パフォーマンス:
-5.39%
1日の値動き範囲:
$22.76
$23.08
1週間の範囲:
$22.18
$23.08
52週間の値動き範囲:
$17.26
$25.80
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
IDNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IDNA
Ishares Genomics Immunology And Healthcare Etf
|
23.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
319.55 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
647.24 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
650.47 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
255.52 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
576.06 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Genomics Immunology And Healthcare Etf (IDNA) 最新ニュース
Ripple Expands Leadership Team with BlackRock Executives Amid Strategic Shifts - AInvest
When (XDNA) Moves Investors should Listen (XDNA:CA) - news.stocktradersdaily.com
(XDNA) Strategic Investment Guide (XDNA:CA) - news.stocktradersdaily.com
IDNA Dividend Declared: Navigating Sustainability and Growth in Healthcare ETFs - AInvest
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
(XDNA) Pivots Trading Plans and Risk Controls (XDNA:CA) - news.stocktradersdaily.com
(XDNA) Risk-Controlled Trading Report (XDNA:CA) - news.stocktradersdaily.com
Objective long/short (XDNA) Report (XDNA:CA) - news.stocktradersdaily.com
(XDNA) Trading Advice (XDNA:CA) - news.stocktradersdaily.com
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal - Benzinga
(XDNA) Stock Trading Blueprint (XDNA:CA) - news.stocktradersdaily.com
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus - Zacks Investment Research
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion - Benzinga
IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (NYSEARCA:IDNA) - Seeking Alpha
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm? - Benzinga
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Future Health: Harnessing Innovations In Healthcare - Syfe
The Healthcare Sector: 5 Things To Know - Syfe
7 Best Biotech ETFs In Canada for March 2025 - Wealth Awesome
ETF Battles: ARKG Vs IDNA Vs GNOM - ETF.com
Has Biotechnology Bottomed Out? - Master Investor
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
IDNA: Continues To Underperform, But With Long-Term Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing - US News Money
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering and Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - InvestorPlace
3 Themes Growth and Tech Investors May Want to Consider in 2023 - Nasdaq
Biotech ETFs Slip After Novavax Cuts 2022 Guidance - ETF Trends
IDNA: A Long Term Prospect, Slowly Overcoming Bearish Rally (NYSEARCA:IDNA) - Seeking Alpha
BlackRock's iShares predicts 3 'megatrend' themes will accelerate in 2022 — and identifies the best ways for investors to capture their gains - Business Insider
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
3 genome ETFs to watch in 2021 - CMC Markets
iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant (NYSEARCA:IDNA) - Seeking Alpha
3 ETFs For More Moderna Bets - Yahoo
2 Biotechnology ETFs That Could Be Good For Diversification - ETF Trends
iShares Lists Cybersecurity and Genomics ETFs - ETF Trends
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
Ishares Genomics Immunology And Healthcare Etf (IDNA) 財務データ
Ishares Genomics Immunology And Healthcare Etf (IDNA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.32%
0.49%
大文字化:
|
ボリューム (24 時間):